Investors & Media

2010 News and Events

Date Title   01/15/10 The Medicines Company Announces Option Grants Under NASDAQ Marketplace Rule 5635 PARSIPPANY, NJ, Jan 15, 2010 (MARKETWIRE via COMTEX) -- The Medicines Company (NASDAQ: MDCO) announced today that in accordance with NASDAQ Marketplace Rule 5635, the Company issued new inducement stock options to five new hires. The inducement stock options cover 6,000 shares of common stock and are classified as non-qualified stock options with an exercise price equal to the fair market value on the grant date. The options have a 10-year term and vest over four years as follows: 25 percent o...  01/05/10 The Medicines Company to Participate in the 28th Annual JP Morgan Healthcare Conference PARSIPPANY, NJ, Jan 05, 2010 (MARKETWIRE via COMTEX) -- The Medicines Company (NASDAQ: MDCO) will present at the 28th Annual JP Morgan Healthcare Conference on Tuesday, January 12th, in San Francisco, beginning at 2:30pm Pacific Standard Time, 5:30pm Eastern Standard Time. Clive A. Meanwell, Chairman and Chief Executive Officer, will provide a company overview and outlook in the presentation. The session will be webcast with a link available at The Medicines Company's website http://www.themed...  01/04/10 The Medicines Company Files Additional Patent Infringement Lawsuits PARSIPPANY, NJ, Jan 04, 2010 (MARKETWIRE via COMTEX) -- The Medicines Company (NASDAQ: MDCO) today announced that it has filed lawsuits against Teva Parenteral Medicines, Inc., Pliva Hrvatska d.o.o. and related entities in the United States District Court for the District of Delaware alleging patent infringement based on Abbreviated New Drug Applications seeking U.S. Food and Drug Administration approval to market and sell generic versions of The Medicines Company's Angiomax(R) product prior to ...